课题基金 / 基金详情

STUDIES OF PHOTOTHERAPY AND FREE RADICAL LYMPHOKINE RELATIONSHIPS

STUDIES OF PHOTOTHERAPY AND FREE RADICAL LYMPHOKINE RELATIONSHIPS
光疗和自由基淋巴因子关系的研究
批准号:
3853218
负责人:
H I PASS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

H I PASS的其他基金

相关文献

中文摘要
翻译
我们实验室继续进行光动力疗法的研究。 (PDT)用二血卟啉乙醚敏化肿瘤细胞 然后用630 nm的光照射。自1990年10月以来,我们已经 体外、体内PDT转化细胞模型的建立 肺癌中经常被激活的k-ras癌基因。这个 模型被发现表现出(1)经典的敏化剂滞留 其他模型的特点,以及(2)可预测的肿瘤消退 用光动力疗法。该模型已被用于研究单抗的使用。 与增敏剂偶联的抗体,以及优越的光动力疗法效果 因为已经证明正常组织有更大的节约性。一只小鼠 实体型腹膜癌模型及致敏剂的研究 并公布了PDT的最大耐受量。大号 光动力疗法对胸腔脏器影响的动物模型研究 显示心脏可以耐受高达40焦耳/平方厘米的焦点光动力疗法, 食道、胸壁和肺。一期人体试验,结合 根治性胸膜剥脱术至5 mm厚的恶性胸膜 胸内-术中接生PDT治疗难治性、局部性 胸部恶性肿瘤一直在进行中。中的光剂量升级 对3名患者进行了从15焦耳/平方厘米到32.5焦耳/平方厘米的队列治疗 焦耳/平方厘米。我们继续治疗梗阻性疾病患者 支气管镜下行光动力治疗的支气管内恶性肿瘤。作为一名 关于PDT诱导肿瘤坏死因子的研究的后续研究, 我们的实验室已经证明了自由基应激本身 过氧化氢或超氧化物可以诱导巨噬细胞产生肿瘤坏死因子, 而自由基诱导化疗可以增加肿瘤坏死因子的产生。 此外,我们已经证明,至少在体外,超氧化物歧化酶模拟物可以, 消除肿瘤坏死因子的细胞毒性。对其他化合物的调查 在预防细胞因子毒性方面的作用在我们的 切片采用体外和体内模型。
英文摘要
Our laboratory has continued its investigation of photodynamic therapy (PDT) by sensitization of malignant cells with dihematoporphyrin ether followed by illumination by 630 nm light. Since October 1990, we have established an in vitro, in vivo model of PDT for cells transformed with the k-ras oncogene which is frequently activated in lung cancer. The model was found to exhibit (1) classic sensitizer retention characteristics of other models, and (2) predictable tumor regression with PDT. The model have been used to investigate the use of monoclonal antibody conjugated to the sensitizer, and superior PDT effects as well as greater sparing of normal tissue has been demonstrated. A murine model of solid peritoneal carcinomatosis, investigating sensitizer delivery, and maximal tolerated dose of PDT was published. A large animal model of PDT investigating the effects on intrathoracic organs revealed that focal PDT up to 40 Joules/cm2 was tolerated by heart, esophagus, chest wall, and lung. A Phase I human trial which combines radical debulking to 5 mm thickness of pleural malignancies followed by intrathoracic-intraoperative delivery of PDT for incurable, localized thoracic malignancies has been ongoing. Light dose escalation in cohorts of three patients has been performed from 15 Joules/cm2 to 32.5 Joules/cm2. We continue to treat patients with obstructing endobronchial malignancies with PDT delivered by bronchoscopy. As a followup on studies revealing PDT induction of tumor necrosis factor, our laboratory has demonstrated that free radical stress itself with hydrogen peroxide or superoxide can induce macrophages to produce TNF, and that radical-inducing chemotherapies can increase TNF production. Moreover, we have demonstrated that SOD-mimics can, at least, in vitro, abrogate TNF cytotoxicity. Investigations of other compounds which may be useful in protecting against cytokine toxicity is continuing in our section with in vitro and in vivo models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDIES ON THE TREATMENT AND CHARACTERISTICS OF THORACIC MALIGNANCIES
  • 批准号:
    3774606
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    H I PASS
  • 依托单位:
STUDIES OF PHOTOTHERAPY FOR THORACIC MALIGNANCIES
  • 批准号:
    3916630
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    H I PASS
  • 依托单位:
STUDIES OF PHOTOTHERAPY FOR THORACIC MALIGNANCIES
  • 批准号:
    3874452
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    H I PASS
  • 依托单位:
STUDIES OF PHOTOTHERAPY FOR THORACIC MALIGNANCIES
  • 批准号:
    3939564
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    H I PASS
  • 依托单位: